医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Ownership Change for Fimet Oy, Manufacturer of Dental Treatment Units

2015年04月29日 PM10:01
このエントリーをはてなブックマークに追加


 

HELSINKI

Fimet Oy specializes in manufacturing and developing dental treatment units. The company operates in Askola, Finland, and through a subsidiary in Shanghai, China. Fimet produces reliable, ergonomically designed dental treatment units for the needs of dentists worldwide. 90% of Fimet sales take place outside of Finland, with the main markets being China, Germany, and France. The turnover of the Fimet Group is approximately 15 million euros. The company employs 120 people, with nearly half of employees located in Finland.

The ownership of Fimet Oy is now changing as the current owners are selling all shares of the company to an investment group headed by the company’s Deputy Managing Director MSc Jukka Perttilä and former Managing Director MSc MBA Turo Levänen. Following this transaction, the current largest individual shareholder, Managing Director and Chairman of the Board MSc Timo Janhunen, will retire. Current Deputy Managing Director Jukka Perttilä will assume the responsibility of Managing Director, and Turo Levänen will become the Chairman of the Board.

Founded by MSc Timo Janhunen, Fimet Oy has been designing, manufacturing, and selling high-quality treatment units for the needs of dental professionals worldwide since the 1980s. It has sold equipment to over fifty countries. Under the leadership of Timo Janhunen, Fimet Oy has grown, become more international, and established a strong market position for its products in China.

In addition to the executive management team members, the investment group acquiring the company is comprised of experienced entrepreneurs and business leaders from the fields of commerce, industry and finance. The investment group includes, among others, family-owned business entrepreneur Klaus Berner (MBA), and economist Antti Kasi. The new owners are committed to long-term development of the company. Among the new owners, Kasi has previous experience in the field of health care services. According to him, one of the key strengths of Fimet Oy is the design and functionality of the company’s products, valued by dentists in demanding markets. Chairman of the Board Turo Levänen notes that the company has excellent opportunities for further development. Its products are technically advanced.

CONTACT

For more information:
Fimet Oy
Turo Levänen
Chairman of
the Board
+358 50 569 7626
turo.levanen@fimet.fi
or
Jukka
Perttilä
Managing Director
+358 40 520 0678
jukka.perttila@fimet.fi

同じカテゴリーの記事 

  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report